- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01723215
Prevention of Combat-related PTSD Using Attention Bias Modification (ABM): A Randomized Controlled Trial
March 17, 2015 updated by: Yair Bar-Haim, Tel Aviv University
Prevention of Posttraumatic Symptoms in IDF Soldiers Using Attention Bias Modification (ABM): A Randomized Controlled Trial
Military deployment to combat zones involves exposure to trauma at a higher than average rate and therefore presents a unique opportunity to study predisposing factors to posttraumatic stress reactions and test strategies designed to prevent and ameliorate posttraumatic symptoms.
Decades of scientific research on the origins of resilience and vulnerability to combat-related posttraumatic stress symptoms revealed various predisposing and protective factors.
All these factors however, offer limited opportunity for systematic pre-deployment prevention efforts.
Considering the magnitude of psychological adjustment difficulties encountered by combat personnel in deployment and the limited access to existing evidence-based therapies for PTSD, the development and testing of a novel evidence-based and theory-driven prevention protocol for these problems is of considerable significance.
The current study translates cognitive-neuroscience knowledge and attention bias modification research into a novel computerized training tool that could be easily delivered to soldiers during different stages of the deployment cycle.
If proved efficacious in reducing risk for posttraumatic symptoms ABMT could be integrated into the Army's resilience training program.
Thus, we propose a longitudinal double-blind randomized controlled study of ABMT in soldiers.
We will assess attention bias and symptoms before deployment, will randomly assign soldiers to either 8 ABMT sessions, 4 ABMT sessions, 8 Placebo training sessions, or no training.
Following 6 months of deployment to combat zone symptoms will be assessed again.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
862
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Beer sheva, Israel
- IDF Military camps
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 28 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- combat soldiers
Exclusion Criteria:
- Fluent Hebrew
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Active ABMT8
Active ABMT8 8 active ABMT sessions (10 min.
each, over 7-8 weeks) designed to promote adaptive threat attendance
|
Active ABMT8 8 active ABMT sessions (10 min.
each, over 7-8 weeks) designed to promote adaptive threat attendance
|
Active Comparator: Active ABMT4
Active ABMT4 4 active ABMT sessions (10 min.
each, over 7-8 weeks) designed to promote adaptive threat attendance
|
Active ABMT4 4 active ABMT sessions (10 min.
each, over 7-8 weeks) designed to promote adaptive threat attendance
|
No Intervention: Control
Control: will not receive any intervention
|
|
Placebo Comparator: Placebo
Placebo: will receive 4 training sessions(10 min.
each, over 7-8 weeks) using the same task and stimuli as in the active arms, but not designed to change attention patterns
|
Placebo: will receive 4 training sessions(10 min.
each, over 7-8 weeks) using the same task and stimuli as in the active arms, but not designed to change attention patterns
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in PTSD symptoms(PCL)
Time Frame: Pre-treatment(baseline), after first deployment, 10 days after combat, 4 months after combat
|
1. pre-treatment 2.after first deployment 3.10 days after combat 4. 4 months after combat
|
Pre-treatment(baseline), after first deployment, 10 days after combat, 4 months after combat
|
Probable PTSD diagnosis(CAPS)
Time Frame: Four months after combat
|
Four months after combat
|
Four months after combat
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in Depression(PHQ-9)) and Anxiety(STAI)
Time Frame: Pre-treatment(baseline), after first deployment, 10 days after combat, 4 months after combat
|
1. Pre-treatment(baseline) 2.after first deployment 3.10 days after combat 4. 4 months after combat
|
Pre-treatment(baseline), after first deployment, 10 days after combat, 4 months after combat
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Attention Bias Scores
Time Frame: Pre-traetment baseline and in deployment
|
Attention bias scores measured in milliseconds using the dot-probe task
|
Pre-traetment baseline and in deployment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Eyal Fruchter, Mental Health Department IDF
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Bar-Haim Y. Research review: Attention bias modification (ABM): a novel treatment for anxiety disorders. J Child Psychol Psychiatry. 2010 Aug;51(8):859-70. doi: 10.1111/j.1469-7610.2010.02251.x. Epub 2010 May 6.
- Bar-Haim Y, Holoshitz Y, Eldar S, Frenkel TI, Muller D, Charney DS, Pine DS, Fox NA, Wald I. Life-threatening danger and suppression of attention bias to threat. Am J Psychiatry. 2010 Jun;167(6):694-8. doi: 10.1176/appi.ajp.2009.09070956. Epub 2010 Apr 15.
- Wald I, Fruchter E, Ginat K, Stolin E, Dagan D, Bliese PD, Quartana PJ, Sipos ML, Pine DS, Bar-Haim Y. Selective prevention of combat-related post-traumatic stress disorder using attention bias modification training: a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2627-36. doi: 10.1017/S0033291716000945. Epub 2016 Jul 5.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2012
Primary Completion (Actual)
February 1, 2015
Study Completion (Actual)
February 1, 2015
Study Registration Dates
First Submitted
November 5, 2012
First Submitted That Met QC Criteria
November 6, 2012
First Posted (Estimate)
November 7, 2012
Study Record Updates
Last Update Posted (Estimate)
March 19, 2015
Last Update Submitted That Met QC Criteria
March 17, 2015
Last Verified
March 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- TelAvivU
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PTSD
-
University of PittsburghCompletedPTSD | Non PTSDUnited States
-
Imperial College Healthcare NHS TrustImperial College LondonRecruiting
-
VA Office of Research and DevelopmentUniversity of California, San DiegoRecruiting
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Active, not recruiting
-
Oregon Health and Science UniversityEnrolling by invitation
-
VA Office of Research and DevelopmentCompleted
-
VA Office of Research and DevelopmentPortland VA Medical CenterActive, not recruiting
-
VA Office of Research and DevelopmentSan Diego Veterans Healthcare SystemCompleted
-
Creighton UniversityCompleted
-
VA Eastern KansasTerminated
Clinical Trials on Active ABMT8
-
Unilever R&DCompleted
-
Novozymes A/SAnalyze & RealizeNot yet recruiting
-
Case Western Reserve UniversityHighland Instruments, Inc.RecruitingDiabetic Neuropathies | Chronic PainUnited States
-
University of California, San DiegoNational Center for Complementary and Integrative Health (NCCIH); United States...CompletedChronic Low Back Pain | Chronic Neck PainUnited States
-
University of California, Los AngelesRecruiting
-
Lund UniversityVinnova; Antidiabetic Food Centre AFCCompleted
-
Chang Gung Memorial HospitalEnrolling by invitationSuspected Non-Alzheimer Disease Pathophysiology (SNAP)Taiwan
-
University Health Network, TorontoPatient-Centered Outcomes Research Institute; M.D. Anderson Cancer Center; Applied... and other collaboratorsActive, not recruitingDysphagiaUnited States, Canada
-
Sophiahemmet UniversityKarolinska Institutet; Linnaeus University; The Swedish School of Sport and Health... and other collaboratorsNot yet recruiting
-
University of California, Los AngelesUCLA Vatche and Tamar Manoukian Division of Digestive Diseases; UCLA Department...CompletedColorectal Neoplasms | Colorectal Cancer | Health ScreeningUnited States